These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32321659)

  • 1. Is Chemotherapy with Carboplatin and 5-Fluorouracil Effective, Worthwhile Palliative Treatment in Recurrent/Metastatic Non-oral Cavity Head and Neck Carcinoma?
    Iqbal MS; Gray I; Jackson M; Kovarik J; Kelly C
    Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):546. PubMed ID: 32321659
    [No Abstract]   [Full Text] [Related]  

  • 2. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Kua VF; Ismail F; Chee Ee Phua V; Aslan NM
    Asian Pac J Cancer Prev; 2013; 14(2):1121-6. PubMed ID: 23621198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
    Burgy M; Barthélémy P; Lefevre F; Dupret-Bories A; Truntzer P; Korenbaum C; Flesch H; Bronner G; Borel C
    Oncology; 2017; 93(1):11-17. PubMed ID: 28423384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
    Jimeno A; Machiels JP; Wirth L; Specenier P; Seiwert TY; Mardjuadi F; Wang X; Kapp AV; Royer-Joo S; Penuel E; McCall B; Pirzkall A; Clement PM
    Cancer; 2016 Dec; 122(24):3803-3811. PubMed ID: 27525588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group study.
    Fountzilas G; Kosmidis P; Sridhar KS; Kalogera-Fountzila A; Banis K; Dimitriadis A; Avramidis V; Nikolaou A; Zaramboukas T; Skarlos D; Vritsios A; Daniilidis I
    Cancer Invest; 1996; 14(3):189-96. PubMed ID: 8630678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
    Suzuki S; Ishikawa K
    J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study.
    Buxó E; Sosa A; Reig O; Victoria I; Caballero M; Grau JJ; Garcia-Morillo M
    Ann Otol Rhinol Laryngol; 2018 Jul; 127(7):456-462. PubMed ID: 29852745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.
    Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Earley CL; Winn RJ; Brooks J; Baez L; Hong WK
    Ann Oncol; 1995 Jan; 6(1):83-5. PubMed ID: 7536031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel plus cisplatin plus fluorouracil versus carboplatin plus fluorouracil-cetuximab in first-line setting in patients with recurrent or metastatic head and neck squamous cell cancer who did not previously receive neoadjuvant or adjuvant chemotherapy, which is standard?
    Mutlu H; Salim DK; Gündüz Ş; Eryılmaz MK; Musri FY; Coşkun HŞ
    J Cancer Res Ther; 2017; 13(3):510-513. PubMed ID: 28862218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy with S-1 and carboplatin for head and neck cancers].
    Watanabe A; Taniguchi M; Tsujie H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():155-9. PubMed ID: 16897993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Bourhis J; Rivera F; Mesia R; Awada A; Geoffrois L; Borel C; Humblet Y; Lopez-Pousa A; Hitt R; Vega Villegas ME; Duck L; Rosine D; Amellal N; Schueler A; Harstrick A
    J Clin Oncol; 2006 Jun; 24(18):2866-72. PubMed ID: 16717293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
    Galetta D; Giotta F; Rosati G; Gebbia V; Manzione L; Di Bisceglie M; Borsellino N; Colucci G
    Anticancer Res; 2005; 25(6C):4445-9. PubMed ID: 16334124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.
    Yossi S; Linot B; Peyraga G; Breheret R; Laccourreye L; Capitain O
    Int J Clin Oncol; 2015 Dec; 20(6):1086-92. PubMed ID: 25931315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
    Tahara M; Kiyota N; Yokota T; Hasegawa Y; Muro K; Takahashi S; Onoe T; Homma A; Taguchi J; Suzuki M; Minato K; Yane K; Ueda S; Hara H; Saijo K; Yamanaka T
    Ann Oncol; 2018 Apr; 29(4):1004-1009. PubMed ID: 29408977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Schultz JD; Bran G; Anders C; Sadick H; Faber A; Hörmann K; Sauter A
    Oncol Rep; 2010 Nov; 24(5):1213-6. PubMed ID: 20878112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.
    Demirci NS; Aksoy S; Özdemir NY; Erdem GU; Ozcelik M; Tanrikulu E; Eren T; Bozkaya Y; Sahin S; Başol F; Aslan SA; Zengin N; Güllü İ
    Curr Med Res Opin; 2017 Mar; 33(3):401-407. PubMed ID: 27817239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Kornek V; Scheithauer W; Glaser C; Toth J; Duman M; Formanek M; Hejna M; Kornfehl J
    Oncology; 1999; 56(1):24-7. PubMed ID: 9885373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin and 5-fluorouracil in advanced and recurrent squamous carcinoma of the head and neck.
    Junor E; Canney P; Yosef H
    Clin Oncol (R Coll Radiol); 1993; 5(1):43-5. PubMed ID: 8424914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.